Compugroup Medical Shares Outstanding vs. Return On Asset
| COP Stock | EUR 15.04 1.02 7.28% |
For Compugroup Medical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Compugroup Medical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Compugroup Medical SE utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Compugroup Medical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Compugroup Medical SE over time as well as its relative position and ranking within its peers.
Compugroup |
Compugroup Medical Return On Asset vs. Shares Outstanding Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Compugroup Medical's current stock value. Our valuation model uses many indicators to compare Compugroup Medical value to that of its competitors to determine the firm's financial worth. Compugroup Medical SE is rated below average in shares outstanding category among its peers. It is rated below average in return on asset category among its peers . The ratio of Shares Outstanding to Return On Asset for Compugroup Medical SE is about 1,582,878,788 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Compugroup Medical's earnings, one of the primary drivers of an investment's value.Compugroup Return On Asset vs. Shares Outstanding
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Compugroup Medical |
| = | 52.23 M |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Compugroup Medical |
| = | 0.033 |
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Compugroup Return On Asset Comparison
Compugroup Medical is rated below average in return on asset category among its peers.
Compugroup Medical Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Compugroup Medical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Compugroup Medical will eventually generate negative long term returns. The profitability progress is the general direction of Compugroup Medical's change in net profit over the period of time. It can combine multiple indicators of Compugroup Medical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
CompuGroup Medical Societas Europaea develops and sells software and information technology services for healthcare sector worldwide. CompuGroup Medical Societas Europaea was founded in 1979 and is headquartered in Koblenz, Germany. COMPUGROUP MED operates under Health Information Services classification in Germany and is traded on Frankfurt Stock Exchange. It employs 5000 people.
Compugroup Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Compugroup Medical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Compugroup Medical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Compugroup Medical's important profitability drivers and their relationship over time.
Use Compugroup Medical in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Compugroup Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Compugroup Medical will appreciate offsetting losses from the drop in the long position's value.Compugroup Medical Pair Trading
Compugroup Medical SE Pair Trading Analysis
The ability to find closely correlated positions to Compugroup Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Compugroup Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Compugroup Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Compugroup Medical SE to buy it.
The correlation of Compugroup Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Compugroup Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Compugroup Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Compugroup Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Compugroup Medical position
In addition to having Compugroup Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Drugs Thematic Idea Now
Drugs
Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. The Drugs theme has 48 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Drugs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Compugroup Stock
To fully project Compugroup Medical's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Compugroup Medical at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Compugroup Medical's income statement, its balance sheet, and the statement of cash flows.